Nephron Segmentation for Renal PBPK

Why Segment the Nephron?

A renal PBPK model needs more than a single kidney compartment when the processes of interest occur at different locations along the nephron. Glomerular filtration delivers drug from plasma into the initial tubular fluid. That fluid then passes through segments with distinct locations, flows, and opportunities for drug exchange with surrounding tissue. A segmental representation provides a place to account for those changes without treating every part of the nephron as one undifferentiated pathway.

The central modelling distinction is between drug mass flow and tubular fluid flow. Fluid flow generally changes as water is reabsorbed. Drug mass flow can also change, but only if drug enters or leaves the tubular lumen, for example through filtration or a segment-specific exchange process. A change in tubular fluid flow alone can change the drug concentration even when the drug mass flow remains constant.

From Filtration to Urine: The Compartment Map

The glomerulus filters water and unbound drug from blood plasma into Bowman’s space. In the earlier material on unbound drug filtration, the filtered drug input is related to the glomerular filtration rate and the unbound plasma concentration. For a drug with unbound plasma concentration \(C_{u,p}\), the filtered drug mass rate is

Here \(Q_{\mathrm{GFR}}\) is a fluid volume per unit time, so concentration must be expressed as drug mass per fluid volume for \(F_{\mathrm{filt}}\) to have units of drug mass per time. This is a tubular input at the start of the pathway, not the flow through every downstream segment.

A useful ordered map is Bowman’s space, the proximal tubule, the loop of Henle, the distal tubule, the connecting tubule, and the collecting duct. A model may combine or subdivide these regions, but it should retain the order in which tubular fluid traverses them. The proximal tubule is an important location for substantial reabsorption and secretion; downstream segments provide further, distinct opportunities for exchange and for changes in water flow. These labels identify locations for model processes; they do not by themselves specify a transporter mechanism or the rate of a process.

The tubular pathway must also be kept distinct from the renal vascular pathway. Renal plasma flow describes plasma delivered through the kidney’s blood vessels; it is not the volume of tubular fluid passing through a nephron segment. Filtered fluid enters the tubule at the glomerulus, while unfiltered plasma continues through renal vessels and supports exchange with renal tissue. The two pathways are coupled, but their flow rates are not interchangeable.

Segment-Level Flow and Mass Balance

Index tubular segments in flow order by \(k\). Let \(Q_{\mathrm{in},k}\) and \(Q_{\mathrm{out},k}\) denote the incoming and outgoing tubular-fluid flow rates, and let \(F_{\mathrm{in},k}\) and \(F_{\mathrm{out},k}\) denote the corresponding drug mass rates in tubular fluid. Luminal concentration is drug mass per fluid volume. At a segment boundary with positive flow, it is the mass rate divided by the fluid flow rate.

Define \(J_k\) as the net rate of drug transfer into the tubular lumen within segment \(k\). Thus \(J_k\) is positive for net addition to tubular fluid and negative for net removal from it. At steady state, the segment drug balance is

If a segment is represented dynamically, the change in drug amount stored in that segment must also be included. For a well-mixed tubular-fluid compartment with drug amount \(A_k\), the corresponding balance is

This dynamic equation is a conservation statement: amount increases when inflow and net luminal addition exceed outflow. A model that represents water movement dynamically must also account for changing fluid volume; drug concentration is then amount divided by the current fluid volume, not a substitute for the drug amount balance.

For fluid, a simple segment-level steady-state balance can be written as \(Q_{\mathrm{out},k}=Q_{\mathrm{in},k}-Q_{\mathrm{water},k}\), where \(Q_{\mathrm{water},k}\) is the net rate of water removed from tubular fluid. A segment with water addition would instead have an increase in outgoing flow. These are fluid balances; they do not imply that drug mass is removed in the same proportion. Any drug exchange must be represented separately in \(J_k\).

Worked Examples in Segmental Bookkeeping

Why the Concentration Formula Follows

The relation \(C=F/Q\) follows directly from the definitions of concentration and mass rate. Over a short time interval \(\Delta t\), a fluid volume \(Q\Delta t\) carrying concentration \(C\) transports drug amount \(C Q\Delta t\). Dividing the transported amount by the interval gives the mass rate \(F=CQ\); rearranging gives \(C=F/Q\), provided \(Q>0\).

This derivation also shows why concentration should not be propagated as though it were conserved. In the water-only example, the mass rate stayed fixed while \(Q\) fell, so \(C=F/Q\) necessarily rose. Conversely, a change in concentration does not by itself establish that drug mass was added or removed. To infer exchange, compare mass rates at the segment boundaries and account for any change in stored amount if the model is dynamic.

Choosing Resolution, Checking the Model, and Knowing Its Limits

A whole-kidney or single-tubule compartment can be adequate when the aim is to represent net renal elimination and there is no need to locate exchange along the tubule. A segmented model is more informative when the question depends on where filtration enters, where net exchange occurs, or how changing tubular flow affects luminal concentrations. More segments are not automatically better: they add parameters and can create poorly constrained estimates if segment-specific data or defensible physiological assumptions are unavailable.

A practical segmentation should therefore be as detailed as the question requires, while keeping enough structure to distinguish the relevant regions. For instance, a model may separate the proximal tubule from downstream segments when proximal versus distal exchange matters, yet combine finer subdivisions if there is no information to support them. Segment names should not be mistaken for evidence that a particular process occurs at a known rate in that compartment.

Several checks help detect implementation errors. First, confirm that each segment’s outlet feeds the next segment’s inlet in the correct anatomical order. Second, check fluid-flow units and ensure \(Q_{\mathrm{out},k}\) is consistent with the model’s water balance. Third, verify drug mass balance by comparing incoming and outgoing mass rates with the stated \(J_k\) and any accumulation. Finally, compare the summed balance across all segments with the net filtered input, other modelled renal inputs, and urinary output.

A frequent error is to apply a single water-reabsorption fraction to drug mass flow as if drug were removed in that same fraction. That is only justified under an explicit assumption that drug follows the removed fluid in that proportion. The correction is to balance water and drug separately: update \(Q\) through the fluid balance, update \(F\) through drug exchange and storage, and then calculate concentration as \(F/Q\). Another error is to use renal plasma flow as the tubular flow in this calculation; these flows describe different pathways and must remain distinct.